ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BP3QZ601
Stock Name / FundiShares Edge MSCI World Quality Factor UCITS ETF
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerIWFQ(GBX) LSE
ETF TickerIS3Q(EUR) F
ETF TickerIS3Q.DE(EUR) CXE
ETF TickerIWFQ.LS(GBX) CXE
ETF TickerIWQU.LS(USD) CXE
ETF TickerIWQU.MI(EUR) CXE
ETF TickerIWQU(EUR) ETF Plus
ETF TickerIWFQ.L(GBP) LSE

Holdings detail for MRK

Stock NameMarks Electrical Group PLC
TickerMRK(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BM8Q5G47
LEI2138007KN8TKPIXIQE92
TickerMRK(EUR) F

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
MRK Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
iShares MSCI ACWI ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
Dow Movers: WMT, MRK
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
MRK April 2026 Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Edge MSCI World Quality Factor UCITS ETF MRK holdings

DateNumber of MRK Shares HeldBase Market Value of MRK SharesLocal Market Value of MRK SharesChange in MRK Shares HeldChange in MRK Base ValueCurrent Price per MRK Share HeldPrevious Price per MRK Share Held
2025-12-04 (Thursday)318,810USD 32,164,741MRK holding decreased by -439958USD 32,164,7410USD -439,958 USD 100.89 USD 102.27
2025-12-03 (Wednesday)318,810USD 32,604,699MRK holding increased by 395325USD 32,604,6990USD 395,325 USD 102.27 USD 101.03
2025-12-02 (Tuesday)318,810MRK holding decreased by -1206USD 32,209,374MRK holding decreased by -377855USD 32,209,374-1,206USD -377,855 USD 101.03 USD 101.83
2025-12-01 (Monday)320,016USD 32,587,229MRK holding decreased by -960048USD 32,587,2290USD -960,048 USD 101.83 USD 104.83
2025-11-28 (Friday)320,016USD 33,547,277MRK holding increased by 64003USD 33,547,2770USD 64,003 USD 104.83 USD 104.63
2025-11-27 (Thursday)320,016USD 33,483,274USD 33,483,2740USD 0 USD 104.63 USD 104.63
2025-11-26 (Wednesday)320,016MRK holding decreased by -1209USD 33,483,274MRK holding decreased by -457360USD 33,483,274-1,209USD -457,360 USD 104.63 USD 105.66
2025-11-25 (Tuesday)321,225USD 33,940,634MRK holding increased by 1689644USD 33,940,6340USD 1,689,644 USD 105.66 USD 100.4
2025-11-24 (Monday)321,225MRK holding decreased by -36243USD 32,250,990MRK holding decreased by -2695082USD 32,250,990-36,243USD -2,695,082 USD 100.4 USD 97.76
2025-11-21 (Friday)357,468USD 34,946,072MRK holding increased by 997336USD 34,946,0720USD 997,336 USD 97.76 USD 94.97
2025-11-20 (Thursday)357,468USD 33,948,736MRK holding decreased by -28597USD 33,948,7360USD -28,597 USD 94.97 USD 95.05
2025-11-19 (Wednesday)357,468USD 33,977,333MRK holding decreased by -493306USD 33,977,3330USD -493,306 USD 95.05 USD 96.43
2025-11-18 (Tuesday)357,468USD 34,470,639MRK holding increased by 1276161USD 34,470,6390USD 1,276,161 USD 96.43 USD 92.86
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRK by Blackrock for IE00BP3QZ601

Show aggregate share trades of MRK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02SELL-1,206101.800100.310 100.459GBX -121,154 86.21 Loss of -17,179 on sale
2025-11-26SELL-1,209105.752104.200 104.355GBX -126,165 85.85 Loss of -22,373 on sale
2025-11-26SELL-1,209105.752104.200 104.355GBX -126,165 85.85 Loss of -22,373 on sale
2025-11-24SELL-36,243102.35599.120 99.444GBX -3,604,131 85.67 Loss of -499,137 on sale
2025-11-17BUY1,34294.74092.675 92.882GBX 124,647 85.41
2025-11-07SELL-4,02986.57085.240 85.373GBX -343,968 85.25 Loss of -479 on sale
2025-11-05SELL-1,34385.38082.912 83.159GBX -111,682 85.26 Profit of 2,817 on sale
2025-11-03BUY2,68486.10082.340 82.716GBX 222,010 85.28
2025-10-31BUY4,02686.46084.560 84.750GBX 341,203 85.28
2025-10-22SELL-2,68688.79087.030 87.206GBX -234,235 85.20 Loss of -5,395 on sale
2025-10-21SELL-2,68487.67086.230 86.374GBX -231,828 85.18 Loss of -3,196 on sale
2025-10-20SELL-1,34287.00085.030 85.227GBX -114,375 85.18 Loss of -68 on sale
2025-10-15SELL-2,68684.69083.610 83.718GBX -224,867 85.19 Profit of 3,962 on sale
2025-10-14SELL-1,34285.68084.150 84.303GBX -113,135 85.20 Profit of 1,198 on sale
2025-10-01SELL-2,69090.75085.190 85.746GBX -230,657 85.14 Loss of -1,633 on sale
2025-09-10SELL-1,344 84.030* 85.35 Profit of 114,706 on sale
2025-09-08SELL-1,34484.32082.820 82.970GBX -111,512 85.36 Profit of 3,206 on sale
2025-09-02SELL-1,34485.50084.340 84.456GBX -113,509 85.35 Profit of 1,207 on sale
2025-08-21SELL-4,03287.32084.600 84.872GBX -342,204 85.34 Profit of 1,904 on sale
2025-08-12SELL-6,72580.94079.670 79.797GBX -536,635 85.42 Profit of 37,836 on sale
2025-07-07SELL-1,34281.54080.150 80.289GBX -107,748 86.00 Profit of 7,665 on sale
2025-06-24SELL-2,68681.46079.090 79.327GBX -213,072 86.38 Profit of 18,934 on sale
2025-06-20SELL-1,34279.92078.600 78.732GBX -105,658 86.49 Profit of 10,416 on sale
2025-06-13SELL-1,34282.44081.450 81.549GBX -109,439 86.79 Profit of 7,038 on sale
2025-06-02BUY1,342 76.250* 87.49
2025-05-30SELL-13,475 76.840* 87.59 Profit of 1,180,321 on sale
2025-05-20BUY1,38779.18077.422 77.597GBX 107,628 88.49
2025-05-14BUY1,384 73.470* 89.09
2025-05-13BUY1,388 76.630* 89.23
2025-05-07BUY1,387 79.120* 89.76
2025-05-02BUY1,38584.71082.950 83.126GBX 115,130 90.06
2025-04-23SELL-1,38680.20078.240 78.436GBX -108,712 90.78 Profit of 17,112 on sale
2025-04-17BUY3,89278.74676.880 77.067GBX 299,943 91.51
2025-04-17BUY3,89278.74676.880 77.067GBX 299,943 91.51
2025-04-14BUY2,74480.01078.360 78.525GBX 215,473 92.13
2025-04-07SELL-1,37183.21079.300 79.691GBX -109,256 93.14 Profit of 18,438 on sale
2025-03-21SELL-1,371 93.110* 94.09 Profit of 128,991 on sale
2025-03-17SELL-1,370 94.790* 94.04 Profit of 128,841 on sale
2025-03-14SELL-1,371 94.570* 94.03 Profit of 128,919 on sale
2025-03-11SELL-1,370 94.730* 94.02 Profit of 128,803 on sale
2025-02-28BUY6,32092.35090.710 90.874GBX 574,324 94.10
2025-02-26SELL-1,34891.37088.860 89.111GBX -120,122 94.34 Profit of 7,042 on sale
2025-02-14SELL-1,34884.76082.094 82.361GBX -111,022 96.55 Profit of 19,132 on sale
2024-12-09SELL-2,704105.070102.330 102.604GBX -277,441 102.22 Loss of -1,041 on sale
2024-12-06SELL-14,828103.950102.690 102.816GBX -1,524,556 102.11 Loss of -10,469 on sale
2024-12-05SELL-1,349104.140101.350 101.629GBX -137,098 101.90 Profit of 371 on sale
2024-12-03SELL-5,396102.450100.620 100.803GBX -543,933 102.02 Profit of 6,578 on sale
2024-12-02SELL-1,350101.850100.460 100.599GBX -135,809 102.38 Profit of 2,398 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,053,2942,0243,869,11627.2%
2025-09-181,184,9228,0053,015,34039.3%
2025-09-171,616,76818,7303,647,85344.3%
2025-09-161,223,7119603,598,70934.0%
2025-09-151,814,7678,4204,295,96242.2%
2025-09-122,018,4637,5573,506,69457.6%
2025-09-111,493,7285,3993,180,82847.0%
2025-09-102,013,1025,3353,313,84760.7%
2025-09-091,075,1375,5052,373,81745.3%
2025-09-082,147,2042,4483,731,34357.5%
2025-09-051,440,1149,9482,983,29648.3%
2025-09-041,439,7261,1215,661,88725.4%
2025-09-031,849,1033,5534,699,60739.3%
2025-09-022,193,136115,1354,314,82650.8%
2025-08-291,545,05711,4203,841,71540.2%
2025-08-281,559,7666,1695,284,88829.5%
2025-08-271,383,4767,8383,737,50637.0%
2025-08-261,328,2351,2292,869,94446.3%
2025-08-252,177,2005,5783,771,31357.7%
2025-08-221,523,3527,4973,248,57546.9%
2025-08-212,449,66018,5405,416,96945.2%
2025-08-201,189,29116,6923,133,34538.0%
2025-08-191,722,6512,3313,737,68946.1%
2025-08-181,150,9372,8222,604,34444.2%
2025-08-151,795,3941,6733,415,80852.6%
2025-08-142,198,5622,2724,496,39848.9%
2025-08-131,885,48019,5373,953,04547.7%
2025-08-121,593,84410,3603,185,66750.0%
2025-08-11990,4053,6052,886,69034.3%
2025-08-081,224,37811,1872,672,27945.8%
2025-08-071,718,6615,3564,504,85038.2%
2025-08-062,028,9271,8824,007,25250.6%
2025-08-051,573,6816,0493,579,53444.0%
2025-08-041,568,9759443,301,80147.5%
2025-08-011,718,70113,8534,079,64242.1%
2025-07-313,367,7552,6646,082,64455.4%
2025-07-302,253,4585,8784,162,63654.1%
2025-07-295,939,07236,24911,111,79553.4%
2025-07-282,243,2356,7394,563,91349.2%
2025-07-251,302,4376,9002,889,20745.1%
2025-07-241,156,3972,5702,732,35142.3%
2025-07-231,879,40020,2804,001,02547.0%
2025-07-221,628,7541,7733,592,84745.3%
2025-07-211,900,56312,5715,188,43236.6%
2025-07-181,536,7621,2463,463,05944.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy